Yihan Wang
Shandong University(CN)Soochow University(CN)
Publications by Year
Research Areas
RNA modifications and cancer, Epigenetics and DNA Methylation, Chronic Myeloid Leukemia Treatments, Advanced biosensing and bioanalysis techniques, Cancer-related gene regulation
Most-Cited Works
- → AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance(2009)1,234 cited
- → Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase(2016)396 cited
- → The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models(2016)321 cited
- → Characterization of Susceptibility of Inbred Mouse Strains to Diabetic Nephropathy(2005)298 cited
- → Structural Mechanism of the Pan‐BCR‐ABL Inhibitor Ponatinib (AP24534): Lessons for Overcoming Kinase Inhibitor Resistance(2010)282 cited
- → Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML(2004)198 cited